US Stock MarketDetailed Quotes
VRAX Virax Biolabs
- 0.6797
- -0.0082-1.19%
Close Apr 18 16:00 ET
- 0.6991
- +0.0194+2.85%
Post 16:57 ET
1.61MMarket Cap-193P/E (TTM)
0.7400High0.6797Low4.82KVolume0.7298Open0.6879Pre Close3.42KTurnover0.32%Turnover RatioLossP/E (Static)2.36MShares5.445052wk High0.18P/B1.02MFloat Cap0.613352wk Low--Dividend TTM1.50MShs Float290.0000Historical High--Div YieldTTM8.77%Amplitude0.6133Historical Low0.7080Avg Price1Lot Size
About Virax Biolabs Company
Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The company was founded by James Foster and Cameron Shaw in 2013 and is headquartered in London, the United Kingdom.
Company Profile
SymbolVRAX
Company NameVirax Biolabs
Listing DateJul 21, 2022
Issue Price5.00
Founded2013
CEOMr. James Foster
MarketNASDAQ
Employees11
Securities TypeOrdinary Shares
Fiscal Year Ends03-31
Address20 North Audley Street
CityLondon
ProvinceGreater London
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeW1K 6LX
Phone44-20-7788-7414
Websitehttp://www.viraxbiolabs.com
Company Executives
- Name
- Position
- Salary
- James Foster
- Chief Executive Officer and Chairman of the Board
- 1.63M
- Cameron Shaw
- Director and Chief Operating Officer
- 1.59M
- Dr. Tomasz George
- Chief Scientific Officer
- 451.25K
- Mark Ternouth
- Chief Technical Officer
- 405.56K
- Jason Davis
- Chief Financial Officer
- 923.50K
- Yair Erez
- Independent Director
- 96.10K
- Evan Norton
- Independent Director
- 96.10K
- Nelson M. Haight
- Independent Director
- 42.18K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg